Pathophysiology
- Essential (primary) hypertension (90–95% of cases): No single identifiable cause. Results from a complex interplay of genetic predisposition, excessive dietary sodium, obesity, physical inactivity, chronic stress (sustained sympathetic activation), and aging-related arterial stiffness. The common pathway is increased peripheral vascular resistance — the arterioles are chronically vasoconstricted, forcing the heart to generate higher pressures to maintain flow.
- Secondary hypertension (5–10%): Caused by an identifiable condition: renal artery stenosis (activates the renin-angiotensin-aldosterone system), chronic kidney disease (impaired sodium and water excretion), pheochromocytoma (catecholamine-secreting adrenal tumor), Cushing syndrome (cortisol excess), primary aldosteronism (Conn syndrome), coarctation of the aorta, and pregnancy-related hypertension (preeclampsia, eclampsia).
- Renin-angiotensin-aldosterone system (RAAS): Renin from the kidneys converts angiotensinogen to angiotensin I, which ACE converts to angiotensin II — a potent vasoconstrictor. Angiotensin II also stimulates aldosterone release, causing sodium and water retention, expanding blood volume, and further raising BP. Many antihypertensive drugs target this system (ACE inhibitors, ARBs).
- Vascular remodeling: Chronic hypertension causes structural changes in the arterial walls — smooth muscle hypertrophy, collagen deposition, and loss of elastic fibers. This stiffening reduces arterial compliance, amplifying systolic pressure and creating a self-reinforcing cycle. Large arteries lose their Windkessel function (ability to buffer pulsatile flow), increasing cardiac afterload.
- Target organ damage: The sustained pressure damages the kidneys (nephrosclerosis, progressive renal failure), heart (left ventricular hypertrophy, eventually dilated cardiomyopathy and heart failure), brain (lacunar infarcts, hemorrhagic stroke, vascular dementia), eyes (hypertensive retinopathy), and peripheral vasculature (accelerated atherosclerosis).
- Malignant hypertension: A rare but life-threatening hypertensive emergency — diastolic pressure often exceeds 120–130 mmHg with evidence of acute organ damage (encephalopathy, papilledema, acute renal failure, pulmonary edema). Requires immediate emergency department management.
Signs and Symptoms
- Usually asymptomatic until dangerous levels or target organ damage occurs — this is the central clinical problem
- Headaches (typically occipital, worse in the morning) — only at very high pressures
- Dizziness, visual disturbances, and epistaxis at severely elevated levels
- Dyspnea on exertion from left ventricular hypertrophy and reduced cardiac reserve
- Ankle edema from chronic fluid retention or early heart failure
- Cognitive changes and memory impairment from chronic cerebrovascular disease
- Nocturia (increased nighttime urination) from impaired renal concentrating ability
- BP measurement is the only reliable detection method — consistent readings above 130/80 mmHg over multiple measurements confirm the diagnosis
Red Flags
- Malignant hypertension (BP > 180/120 with symptoms): severe headache, visual changes, confusion, chest pain, dyspnea, seizures — call 911; hypertensive emergency
- New neurological deficit (speech difficulty, facial droop, unilateral weakness) in a hypertensive client — possible stroke. Call 911
- Sudden severe chest pain with hypertension — possible aortic dissection or MI. Call 911
- White coat hypertension may produce falsely elevated readings — consider ambulatory monitoring if in-clinic readings are consistently elevated but the client reports normal readings elsewhere
Massage Therapy Considerations
- Relaxation massage is therapeutically indicated: Slow-stroke back massage, Swedish relaxation techniques, and parasympathetic-activating approaches have been demonstrated to temporarily reduce both systolic and diastolic blood pressure. Massage directly counters the sympathetic dominance and chronic stress that drive essential hypertension.
- Blood pressure monitoring: Check BP before and after sessions for clients with known or suspected hypertension. Document readings. If pre-session BP is significantly elevated (systolic > 180 or diastolic > 110), defer vigorous treatment and contact the client's physician.
- Avoid techniques that raise BP: Deep abdominal pressure, vigorous circulatory massage, heavy tapotement, and Valsalva-inducing positions all transiently increase blood pressure and cardiac workload.
- Positioning: Side-lying or semi-reclined may be more comfortable for clients with central obesity. Supine with slight head elevation is preferred over fully flat for clients with mild cardiac congestion.
- Slow position transitions: Multiple classes of antihypertensive medications cause orthostatic hypotension — ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, alpha-blockers, and diuretics. Allow extra time for transitions from supine to seated to standing. Instruct the client to sit on the edge of the table for 30 seconds before standing.
- Hydrotherapy caution: Mild warmth for relaxation is appropriate. Avoid extreme heat (causes vasodilation and compensatory tachycardia, increasing cardiac demand), extreme cold (causes vasoconstriction and acute BP spike), and contrast hydrotherapy (cardiovascular stress).
- Diuretic awareness: Clients on diuretics (hydrochlorothiazide, furosemide) may be dehydrated with electrolyte imbalances. Ensure hydration is available. They may also need bathroom access during the session. Nutrient depletion note: Diuretics deplete potassium and magnesium, causing muscle cramps and fatigue that may not respond to massage. ACE inhibitors deplete zinc, contributing to poor wound healing. Clients on multiple antihypertensives experience compounding depletion — persistent cramps in a client on a diuretic + ACE inhibitor may have a pharmacological explanation. See pharmacology-for-massage-therapists/drug-nutrient-depletion-reference.
- Statin overlap: Many hypertensive clients are also on statins for concurrent dyslipidemia — be aware of statin-related myalgias (see atherosclerosis).
CMTO Exam Relevance
- Category A7 — Systemic Conditions (Cardiovascular)
- Hypertension is the most common modifiable cardiovascular risk factor — the "silent killer" concept is heavily tested
- BP classification (2017 guidelines): Normal < 120/80, Elevated 120–129/< 80, Stage 1 HTN 130–139/80–89, Stage 2 HTN ≥ 140/≥ 90, Hypertensive crisis > 180/> 120
- Know the RAAS pathway (renin → angiotensin I → ACE → angiotensin II → aldosterone) and which drugs target it (ACE inhibitors, ARBs)
- Orthostatic hypotension from antihypertensives is a commonly tested medication effect relevant to MT practice
- White coat hypertension versus nocturnal non-dipping — both are testable concepts affecting clinical interpretation
Key Takeaways
- Hypertension is usually asymptomatic until target organ damage occurs. Consistent BP readings above 130/80 mmHg are the only reliable detection method
- Relaxation massage directly counters sympathetic dominance and has been shown to temporarily reduce blood pressure — therapeutically indicated for stable hypertension
- Avoid deep abdominal pressure, vigorous circulatory massage, extreme heat or cold, and Valsalva-inducing positions — all transiently increase BP and cardiac demand
- Multiple classes of antihypertensive medications cause orthostatic hypotension. Always allow extra time for position transitions
- Malignant hypertension (BP > 180/120 with symptoms) is a medical emergency requiring immediate emergency services
- Check BP before and after sessions for hypertensive clients. Defer vigorous treatment if systolic exceeds 180 or diastolic exceeds 110
- Hypertension is the most common modifiable cardiovascular risk factor a massage therapist will encounter — screening and awareness are essential